Thiogalactoside transacetylase, the lacA gene product, confers selective advantage to cells of Escherichia coli K-12 growing on 83-galactosides in the presence of non-metabolizable analogues.
; and (iii) it must be cleaved by the hydrolase in the principal reaction (26) . Because each of these proteins has a special function, it might be impossible to superimpose on them the same spectrum of ligand specificity. On the other hand, if the specificities of the proteins are not completely concordant, metabolic predicaments might arise. For instance, a compound that qualifies as a transport substrate and as an inducer may not be hydrolyzable. Such a compound may accumulate to the detriment of the cell. (Growth retardation of a lacI-constitutive mutant of E. coli ML by isopropyl-,3-thiogalactose [IPTG] or thiomethyl-(8-D-galactoside [TMG] was demonstrated with succinate as the source of carbon and energy [25] .) A more common situation might be the incidental uptake of non-metabolizable structural analogues while the cell is utilizing physiological 3-galactosides. In such a case an analogue merely has to satisfy the steric requirements of the permease, which are rather low. (The influx Km values for lactose and TMG are close to 0.5 mM [15, 20, 31] .) By what measure can a cell protect itself against this kind of contingency? A clue is provided by the observation that acetylated IPTG and TMG formed under the influence of the transacetylase (32, 33) are discharged into the medium, and that the acetylated compound, in contrast to the free form, cannot be pumped into the cell (29) . The presence or absence of the transacetylase was shown not to affect the transport of free TMG (6) . Fig. 1 .
Although the number of utilizable and nonutilizable f3galactosides employed in this preliminary study is limited, the striking outcome of the growth competition experiments strongly suggests that the fourth gene product of the lac system, thiogalactoside transacetylase, serves as a backup device to avert metabolic congestion. The benefit of the removal of the interfering compounds clearly outweighs the expenditure of energy. Probably also of adaptive significance are the high Km values of this enzyme for its acetyl accepting substrates (0.77 M for IPTG [1, 18] ), which allow the cell to mobilize the energy-consuming mechanism to an extent that is commensurate with the prevailing level of an undesirable substance. Additionally, it might be of relevance to note that a number of galactosides other than lactose are found in milk (22) , and the substrate specificity of the transacetylase is not limited to thio-compounds. At 2 mM, p-nitrophenyl f8-r-galactoside is twice as active as a substrate than IPTG (1, 18). Another important property of this enzyme that should not be overlooked is its complete inactivity towards lactose (18 2 antibiotic medium); (ii) eosin-methylene blue-lactose; (iii) D-arabinose minimal medium; and (iv) DL-1,2-propanediol minimal medium. The first two agar plates gave the total cell count, whereas media in (iii) and (iv) gave the cell numbers of strains 155 and 160, respectively. Once the culture density had reached 200 Klett units (5 x 108 cellslml), a sample was reinoculated iktoa 500 ml ofprewarmed fresh medium to give a dens(ty of 104 cellslml, and the incubation was continued. IPTG was added after about 50 generations, indicated by the arrow, and the composition of the population was sampled for another 50 generations. 
NOTES
With respect to the evolutionary status of the lac operon, it might be cited that Shigella dysenteriae, which is believed to be undergoing retrogressive change in this genetic system because of the absence of an intact lacY gene (17) , apparently also lost the lacA gene (1). The same may apply to Salmonella typhimurium LT-2 (1).
The lack of a thiogalactoside transacetylase need not be a sign of decline or primitiveness in a dissimilatory system for lactose. Transport mechanisms that are highly discriminatory, such as the phosphotransferase system for lactose, may have little use for this enzyme as an accessory. It might be rewarding to examine some of these systems in gram-positive organisms to see if this is true. The non-utilizable glucose analogue, a-methylglucoside, is taken up by the cells and trapped in the cytoplasm in phosphorylated form through the intervention of a phosphotransferase system. In this case, the detoxification process seems to be by de- phosphorylation. Furthermore, the presence of glucose hastens the expulsion of the analogue (8, 30) .
Finally, it is tempting to imagine an evolutionary connection between metabolic safeguards such as thiogalactoside transacetylase and certain defense mechanisms against antibiotics conferred by drug resistance factors (RTF) (2). Chloramphenicol and kanamycin can both be inactivated by RTF-specified transacetylases (19 
